HUMA, HUMAW · CIK 0001818382 · operating
Humacyte, Inc. (HUMA) is a biological products, (no diagnostic substances) company incorporated in DE, listed on the Nasdaq. With a market capitalization of $224 million, Humacyte, Inc. is a micro-cap company. The stock currently trades at $1.12, up 0.36% today, with a 52-week range of $0.88–$3.94.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-1.26 | $-1.26 | -17.8% | |
| 2023 | $-1.07 | $-1.07 | -791.7% | |
| 2022 | $-0.12 | $-0.12 | +81.8% | |
| 2021 | $-0.66 | $-0.66 | — | |
| 2020 | — | — | — |